UNIVERSITY OF SOUTH FLORIDA

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1956-01-01

Employees: 10K

Market Cap: -

Website: http://www.usf.edu

Clinical Trials

Study to Determine the Safety and Tolerability of Varenicline (Chantix®) in Treating Spinocerebellar Ataxia Type 3

Phase 2

Completed

Conditions: Spinocerebellar Ataxia Type 3

Interventions: Drug: varenicline
Drug: placebo

First Posted Date: 2009-10-09

Last Posted Date: 2012-06-18

Lead Sponsor: University of South Florida

Target Recruit Count: 20

Registration Number: NCT00992771

Locations: 🇺🇸
University of South Florida, Tampa, Florida, United States
🇺🇸
University of Florida, Gainesville, Florida, United States
🇺🇸
University of California - Los Angeles, Los Angeles, California, United States

Cyproheptadine Hydrochloride and Nutritional Supplementation in Treating Young Patients With Weight Loss With Cancer

Phase 2

Terminated

Conditions: Leukemia
Lymphoma
Malnutrition
Myelodysplastic Syndromes
Unspecified Childhood Solid Tumor, Protocol Specific
Weight Changes

Interventions: Drug: cyproheptadine hydrochloride
Dietary Supplement: Ensure
Dietary Supplement: PediaSure

First Posted Date: 2009-07-30

Last Posted Date: 2014-04-02

Lead Sponsor: University of South Florida

Target Recruit Count: 9

Registration Number: NCT00949117

Strategies To Prevent Pneumonia 2 (SToPP2)

Phase 2

Completed

Conditions: Ventilator-Associated Pneumonia
Mechanical Ventilation Complication
Infections, Hospital

Interventions: Procedure: Pre-intubation CHX
Procedure: Control

First Posted Date: 2009-05-06

Last Posted Date: 2016-01-11

Lead Sponsor: University of South Florida

Target Recruit Count: 314

Registration Number: NCT00893763

Locations: 🇺🇸
Virginia Commonwealth University, Richmond, Virginia, United States

Videophone Administered Cognitive-Behavioral Therapy for Pediatric Obsessive-Compulsive Disorder

Phase 2

Completed

Conditions: Obsessive Compulsive Disorder

Interventions: Behavioral: Wait-list control
Behavioral: Cognitive-behavioral therapy

First Posted Date: 2009-04-15

Last Posted Date: 2015-06-11

Lead Sponsor: University of South Florida

Target Recruit Count: 31

Registration Number: NCT00881465

Locations: 🇺🇸
University of South Florida, St. Petersburg, Florida, United States

Losartan in Treating Pulmonary Fibrosis in Patients With Stage I, II, or III Non-Small Cell Lung Cancer

Not Applicable

Withdrawn

Conditions: Pulmonary Complications
Radiation Fibrosis
Dyspnea
Lung Cancer

Interventions: Drug: Losartan

First Posted Date: 2009-04-13

Last Posted Date: 2017-05-02

Lead Sponsor: University of South Florida

Registration Number: NCT00880386

Losartan in Treating Patients With Idiopathic Pulmonary Fibrosis

Not Applicable

Completed

Conditions: Precancerous Condition

Interventions: Drug: losartan

First Posted Date: 2009-04-13

Last Posted Date: 2021-02-21

Lead Sponsor: University of South Florida

Target Recruit Count: 20

Registration Number: NCT00879879

Locations: 🇺🇸
University of Cincinnati, Cincinnati, Ohio, United States

D-Cycloserine Augmentation of Therapy for Pediatric Obsessive-Compulsive Disorder

Phase 2

Completed

Conditions: Obsessive-compulsive Disorder

Interventions: Behavioral: Cognitive-behavioral therapy
Drug: Placebo pill
Drug: D-cycloserine

First Posted Date: 2009-03-18

Last Posted Date: 2012-10-17

Lead Sponsor: University of South Florida

Target Recruit Count: 30

Registration Number: NCT00864123

Locations: 🇺🇸
University of South Florida, St. Petersburg, Florida, United States

Reduction of Endometritis After Cesarean Section With the Routine Use of Methergine

Not Applicable

Completed

Conditions: Endometritis

Interventions: Drug: Methergine

First Posted Date: 2009-03-10

Last Posted Date: 2012-09-19

Lead Sponsor: University of South Florida

Target Recruit Count: 44

Registration Number: NCT00858832

Locations: 🇺🇸
Tampa General Hospital, Tampa, Florida, United States

Pilot Study of Varenicline (Chantix®) in the Treatment of Friedreich's Ataxia

Phase 2

Terminated

Conditions: Friedreich's Ataxia

Interventions: Drug: varenicline
Drug: placebo

First Posted Date: 2008-12-08

Last Posted Date: 2012-07-24

Lead Sponsor: University of South Florida

Target Recruit Count: 28

Registration Number: NCT00803868

Locations: 🇺🇸
University of South Florida, Tampa, Florida, United States
🇺🇸
The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, United States

Keppra for Cervical Dystonia

Phase 2

Terminated

Conditions: Cervical Dystonia

First Posted Date: 2008-09-26

Last Posted Date: 2018-11-23

Lead Sponsor: University of South Florida

Target Recruit Count: 17

Registration Number: NCT00760318

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy